Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
18,695
currently held
Exits tracked
7,447
hand-checked
Sectors covered
405
across the portfolio
Countries covered
163
from every market
24,078 companies · Page 387 of 482
Promethean Power Systems
Aster II
EnergyIndia· Entry 2018Aster
Prometheus Materials
Sofinnova Industrial Biotech
Industry / Biotech
United States· Entry 2022Sofinnova Partners
ProMik
DBAG ECF IV
Industrials
Germany· Entry 2023Deutsche Beteiligungs AG
Promimic
Rosetta Capital IV
MedTech
Sweden· Entry 2013Rosetta Capital
Promise Gluten Free
Mayfair Equity Partners II
FoodTech
Ireland· Entry 2017Mayfair Equity Partners
Prompt Associates
Summit Partners Portfolio
Business Services
USASummit Partners
Promus
XAnge 04
Food
France· Entry 2023XAnge
ProNoïa
Cerea Mezzanine IV
PronoKal Group
Lenbach Equity Opportunities III
Healthcare
Spain· Entry 2025DUBAG Group
Pronto!
Latin American Private Equity Fund VII
ConsumerBrazilAdvent International
ProofID
Maven UK Regional Buyout Fund
Cybersecurity
UK· Entry 2022Maven Capital Partners
Proofpoint
Thoma Bravo Flagship
Software
USAThoma Bravo
ProPay
General Atlantic Portfolio
Financials
United StatesGeneral Atlantic
Propello Cloud
DSW Ventures
SaaS
UK· Entry 2022DSW Venture Capital
PROPER SNACKS
Exponent Private Equity Partners IV
Consumer
UK· Entry 2021Exponent Private Equity
Property Brands
PSG Fund III
Software
USAPSG Equity
Property Finder
Francisco Partners Management LP
TMTUAE· Entry 2025Francisco Partners
Property Ventures
Media Ventures Evergreen Holding
Real Estate
Germany· Entry 2016Media Ventures
Propertybase
Providence Strategic Growth Fund
Software
USAPSG Equity
PropertyScout
Partech Seed
MarketplaceSingaporePartech Partners
Prophesee
Robert Bosch Venture Capital Fund IV
TMT
France· Entry 2014Bosch Ventures
Prophix
Hg Genesis 9
SoftwareCanada· Entry 2021Hg
Propriété-privées.com
Pragma Capital III
TMT
France· Entry 2016Sparring Capital
Propriétés Privées
Abénex VI
Real Estate
France· Entry 2022Abénex
Proprio
BOLD Capital Partners Fund I
Healthcare
FranceBOLD Capital Partners
Propseller
Partech Seed
MarketplaceSingaporePartech Partners
PropServ
Jenson SEIS Fund
TMT
United KingdomJenson Funding Partners
Propster
Axeleo Proptech 1
Software
Austria· Entry 2025Axeleo Capital
ProQR Therapeutics
Sofinnova Capital IX
Healthcare / Biotech
Netherlands· Entry 2018Sofinnova Partners
ProRata.ai
BOLD Capital Partners Fund I
Software
FranceBOLD Capital Partners
PROS
Thoma Bravo Fund
TMT
USAThoma Bravo
Proscia
Hitachi Ventures Fund II
MedTech
United States· Entry 2022Hitachi Ventures
Prose
ISAI Venture IV
Consumer
USA· Entry 2020Isai Gestion
Proservvi Banco de Serviços
Latin American Private Equity Fund VII
FinancialsBrazilAdvent International
Prosion
Freigeist Deep-Tech Evergreen
Biotech
Germany· Entry 2022Freigeist Capital
Prosol
Cobepa
Healthcare
Italy· Entry 2025Cobepa
Prosolia
InfraVia European Fund VI
Infrastructure
France· Entry 2026InfraVia Capital Partners
Proson
FPCI Capitem 1
Services
France· Entry 2016Capitem Partenaires
Prosper
MMC Ventures EIS Fund
Financials
USA· Entry 2023MMC Ventures
PROTEC BARTHELEMY
PRISTINE Portfolio
Business Services
France· Entry 2021PRISTINE
Protec Groupe
La Maison Partners
Industrials
France· Entry 2024La Maison Partners
PROTEC VILLEBON
PRISTINE Portfolio
Business Services
France· Entry 2020PRISTINE
Protecht
PSG Fund II
Software
USAPSG Equity
Protein Distillery
Green Generation Fund I
FoodTech
Germany· Entry 2024Green Generation Fund
Protembal
Garibaldi Participations SCR
Industrials
France· Entry 2019Garibaldi Participations
Protembis
Innovationsstarter Fonds Hamburg I
MedTech
Germany· Entry 2015IFB Innovationsstarter
Proteon...
Health for Life Capital
Santé animale /...Poland· Entry 2022Seventure Partners
Protera
Pamlico Capital
Software
USA· Entry 2020Pams
Proteros Biostructures
Inflexion Partnership Capital Fund II
Healthcare
Germany· Entry 2024Inflexion
ProTgen
Boehringer Ingelheim Venture Fund
Biotech
United States· Entry 2024Boehringer Ingelheim Venture Fund